Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trialRobin Kate Kelley, Ming‐Huang Chen, Thomas Yau et al.|The Lancet|2023Cited by 1k
Doxorubicin-induced ovarian toxicityIrit Ben‐Aharon, Ruth Shalgi|Reproductive Biology and Endocrinology|2010Cited by 166
Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control StudyIrit Ben‐Aharon, David P. Kelsen|JMIR Public Health and Surveillance|2023Cited by 9